August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

Girl With Waterdrop-Like Papules: What’s Your Diagnosis?

A teenager with atopic dermatitis presented with several painless, flesh-colored papules limited to the trunk. Dermoscopy and biopsy show selective loss of elastic fibers after prior molluscum contagiosum. What’s your diagnosis?

Conexiant

August 26, 2025

Are Daily Drinks Causing Hair Loss?

Comprehensive analysis reveals specific dietary interventions that significantly impact hair health, with some beverages showing harmful effects.

Conexiant

August 25, 2025

Baricitinib Aids Eyebrow, Eyelash Regrowth in Alopecia Areata

This study highlights baricitinib’s effectiveness in promoting eyebrow and eyelash regrowth in patients with alopecia areata across two phase III clinical trials.

Conexiant

August 25, 2025

Did Politics Delay CDC Measles Response?

Emails and interviews show CDC scientists were sidelined during the West Texas surge, leaving local officials without guidance as cases spread across the US and into Mexico.

KFF Health News

August 22, 2025

Perceived Dermatologic Side Effects of Cancer Treatment: Pilot Survey Findings

A recent study found that many people misunderstand how common skin, hair, and nail side effects are during cancer treatment—and those fears may lead some to avoid or delay care.

The ASCO Post

August 21, 2025

Six Evidence-Based Strategies Transform Clinical Listening

New research identifies six practical approaches to values-driven listening that enhance patient trust, reduce burnout, and improve care quality.

Conexiant

August 19, 2025

AAP Vaccine Recommendations Veer From ACIP

AAP released 2025 evidence-based US childhood and adolescent immunization schedule with updates for RSV, influenza, COVID-19, HPV, and meningococcal vaccines.

Conexiant

August 14, 2025

Thai Trial Tests Turmeric Emulgel Skin Safety

Thai investigators test a botanical emulgel formulation to identify early safety signals related to skin irritation and allergenicity before advancing to patient trials.

Conexiant